---
schema_version: "secwatch.filing_event.v1"
accession: "0001012975-26-000195"
form_type: "8-K"
ticker: "ORMP"
cik: "0001176309"
company_name: "ORAMED PHARMACEUTICALS INC."
filed_at: "2026-02-20T23:59:59+00:00"
generated_at: "2026-05-16T01:23:58.318224+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Oramed receives warrant to buy 100k Scilex shares at $20 in exchange for deferring amortization payment

## Summary
- Oramed deferred its right to receive an amortization payment from Scilex due Oct 1, 2025; payment was made in Nov 2025.
- Oramed received a warrant to purchase 100,000 shares of Scilex common stock at $20.00 per share, expiring Dec 13, 2029.
- Warrant issued under Section 4(a)(2) and Rule 506(b); Scilex agreed to file resale registration statement.
- Beneficial ownership limited to 4.99% (can be raised to 9.99% with 61 days' notice).
- Warrant immediately exercisable; exercise price subject to anti-dilution adjustments with floor of $8.22.

## SEC filing metadata
- accession: 0001012975-26-000195
- form_type: 8-K
- ticker: ORMP
- cik: 0001176309
- company_name: ORAMED PHARMACEUTICALS INC.
- filed_at: 2026-02-20T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/0001012975-26-000195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/ormp-20260219.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001012975-26-000195
- JSON: https://secwatch.observer/filing/0001012975-26-000195.json
- Plain text: https://secwatch.observer/filing/0001012975-26-000195.txt

## Key facts
- Material Agreements
  ORAMED PHARMACEUTICALS INC. entered into Warrant Agreement with Scilex Holding Company (effective 2026-02-19).
  - Action: entry
  - Counterparty: Scilex Holding Company
  - Effective: 2026-02-19
  source text: On February 19, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into a Warrant Agreement (the “Warrant Agreement”) with Scilex Holding Company (“Scilex”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1176309/000101297526000195/0001012975-26-000195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.